Dr. Aytekin Oto is Professor of Radiology and Surgery, and Chair of the Department of Radiology at the University of Chicago. Dr. Oto has a wide range of experience and expertise in the imaging of diseases affecting abdomen and pelvis. His research interest focus is development and clinical application of novel prostate MRI acquisition and interpretation so as to facilitate and improve the efficiency of prostate cancer and develop image guided prostate therapy options for the appropriate patients diagnosed with prostate cancer. His research has resulted in more than 200 publications and over 150 scientific exhibits at national and international meetings. The two overarching aims of his research are “non-invasive and accurate diagnosis of aggressive prostate cancer using MR imaging“ and “eradication of localized prostate cancer with minimal complications using minimally invasive treatment methods”. His group has already has developed new MR sequences, pilot CAD software for prostate MRI and tested MR guided therapy methods such as laser and focused ultrasound ablation in clinical and pre-clinical studies. He has several industry, foundation and NIH grants and serves at the Editorial Board of Radiology. Dr. Oto received numerous awards including Distinguished Investigator Award, RSNA honored educator award and Distinguished Senior Clinician Award.
Cleveland Clinic Foundation
Cleveland, Ohio
- Abdominal Imaging Fellowship
1998
Hacettepe University
Ankara, Turkey
- Diagnostic Radiology
1997
Hacettepe University
Ankara, Turkey
MD - Medical School
1993
A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life.
A Contemporary Report of Low-Dose-Rate Brachytherapy for Prostate Cancer Using MRI for Risk Stratification: Disease Outcomes and Patient-Reported Quality of Life. Cancers (Basel). 2023 Feb 20; 15(4).
PMID: 36831677
Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard Tofts model in the diagnosis of prostate cancer.
Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard Tofts model in the diagnosis of prostate cancer. Res Sq. 2023 Feb 08.
PMID: 36798227
Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI. Radiology. 2022 11; 305(2):399-407.
PMID: 35880981
Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion.
Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion. Magn Reson Med. 2022 11; 88(5):2298-2310.
PMID: 35861268
Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging.
Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging. Abdom Radiol (NY). 2022 07; 47(7):2500-2508.
PMID: 35583823
ACR Appropriateness Criteria? Staging and Surveillance of Testicular Cancer: 2021 Update.
ACR Appropriateness Criteria? Staging and Surveillance of Testicular Cancer: 2021 Update. J Am Coll Radiol. 2022 05; 19(5S):S194-S207.
PMID: 35550802
Prostate MRI: Is Endorectal Coil Necessary?-A Review.
Prostate MRI: Is Endorectal Coil Necessary?-A Review. Life (Basel). 2022 Apr 11; 12(4).
PMID: 35455060
Real-Time MRI-Guided Prostate Interventions.
Real-Time MRI-Guided Prostate Interventions. Cancers (Basel). 2022 Apr 07; 14(8).
PMID: 35454773
Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI.
Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI. Radiology. 2022 06; 303(3):588-589.
PMID: 35258378
Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures.
Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. Abdom Radiol (NY). 2022 02; 47(2):801-813.
PMID: 34878579